Effect of NMSO3 treatment in a murine model of human metapneumovirus infection

References

1. Alvarez R., Harrod K. S., Shieh W. J., Zaki S., Tripp R. A. 2004; Human metapneumovirus persists in BALB/c mice despite the presence of neutralizing antibodies. J Virol 78:14003–14011 [CrossRef]
   [Google Scholar]
2. Castro S. M., Guerrero-Plata A., Suarez-Real G., Adegboyega P. A., Colasurdo G. N., Khan A. M., Garofalo R. P., Casola A. 2006; Antioxidant treatment ameliorates respiratory syncytial virus-induced disease and lung inflammation. Am J Respir Crit Care Med 174:1361–1369 [CrossRef]
   [Google Scholar]
3. Guerrero-Plata A., Casola A., Garofalo R. P. 2005; Human metapneumovirus induces a profile of lung cytokines distinct from that of respiratory syncytial virus. J Virol 79:14992–14997 [CrossRef]
   [Google Scholar]
4. Guerrero-Plata A., Casola A., Suarez G., Yu X., Spetch L., Peeples M. E., Garofalo R. P. 2006; Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus. Am J Respir Cell Mol Biol 34:320–329 [CrossRef]
   [Google Scholar]
5. Haeberle H. A., Kuziel W. A., Dieterich H. J., Casola A., Gatalica Z., Garofalo R. P. 2001; Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1 α in lung pathology. J Virol 75:878–890 [CrossRef]
   [Google Scholar]
6. Hamelin M. E., Boivin G. 2005; Human metapneumovirus: a ubiquitous and long-standing respiratory pathogen. Pediatr Infect Dis J 24:S203–S207 [CrossRef]
   [Google Scholar]
7. Hamelin M. E., Yim K., Kuhn K. H., Cragin R. P., Boukhvalova M., Blanco J. C., Prince G. A., Boivin G. 2005; Pathogenesis of human metapneumovirus lung infection in BALB/c mice and cotton rats. J Virol 79:8894–8903 [CrossRef]
   [Google Scholar]
8. Hamelin M. E., Prince G. A., Boivin G. 2006; Effect of ribavirin and glucocorticoid treatment in a mouse model of human metapneumovirus infection. Antimicrob Agents Chemother 50:774–777 [CrossRef]
   [Google Scholar]
9. Kimura K., Mori S., Tomita K., Ohno K., Takahashi K., Shigeta S., Terada M. 2000; Antiviral activity of NMSO3 against respiratory syncytial virus infection in vitro and in vivo. Antiviral Res 47:41–51 [CrossRef]
   [Google Scholar]
10. Kolli D., Bataki E., Spetch L., Guerrero-Plata A., Milligan G. N., Garofalo R. P., Casola A. 2008; T lymphocytes contribute to antiviral immunity and pathogenesis in experimental human metapneumovirus infection. J Virol (18 June; Epub ahead of print).doi: 10.1128/JVI.00699-08
    [Google Scholar]
11. Miller A. L., Bowlin T. L., Lukacs N. W. 2004; Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo. J Infect Dis 189:1419–1430 [CrossRef]
    [Google Scholar]
12. Shodai T., Suzuki J., Kudo S., Itoh S., Terada M., Fujita S., Shimazu H., Tsuji T. 2003; Inhibition of P-selectin-mediated cell adhesion by a sulfated derivative of sialic acid. Biochem Biophys Res Commun 312:787–793 [CrossRef]
    [Google Scholar]
13. van den Hoogen B. G., de Jong J. C., Groen J., Kuiken T., de Groot R., Fouchier R. A., Osterhaus A. D. 2001; A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 7:719–724 [CrossRef]
    [Google Scholar]
14. Wyde P. R., Chetty S. N., Jewell A. M., Boivin G., Piedra P. A. 2003; Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro. Antiviral Res 60:51–59 [CrossRef]
    [Google Scholar]
15. Wyde P. R., Moylett E. H., Chetty S. N., Jewell A., Bowlin T. L., Piedra P. A. 2004; Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by NMSO3 in tissue culture assays. Antiviral Res 63:51–59 [CrossRef]
    [Google Scholar]